Andrew Obenshain, President and CEO at bluebird bio, Inc. (BLUE), sold 1,879 shares at $0.90 ($2K) on 2024-02-05, disclosed to the SEC on 2024-02-06.
Seasonal sale ($2k) by President and CEO — this insider has traded BLUE in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| BLUE | SELL | 2025-01-08 | $1K | — | Filing → |
| BLUE | SELL | 2024-12-12 | $408 | — | Filing → |
| BLUE | SELL | 2024-10-02 | $18K | — | Filing → |